PuSH - Publication Server of Helmholtz Zentrum München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Álvarez Hernández, E.* ; Kahl, S.* ; Seelig, A. ; Begovatz, P.* ; Irmler, M. ; Kupriyanova, Y.* ; Nowotny, J.* ; Nowotny, P.* ; Herder, C.* ; Barosa, C.* ; Carvalho, F.P.* ; Rozman, J. ; Neschen, S. ; Jones, J.G.* ; Beckers, J. ; Hrabě de Angelis, M. ; Roden, M.*

Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance.

J. Clin. Invest. 127, 695-708 (2017)
Publ. Version/Full Text Research data DOI PMC
Open Access Gold
BACKGROUND: Dietary intake of saturated fat is a likely contributor to nonalcoholic fatty liver disease (NAFLD) and insulin resistance, but the mechanisms that initiate these abnormalities in humans remain unclear. We examined the effects of a single oral saturated fat load on insulin sensitivity, hepatic glucose metabolism, and lipid metabolism in humans. Similarly, initiating mechanisms were examined after an equivalent challenge in mice. METHODS: Fourteen lean, healthy individuals randomly received either palm oil (PO) or vehicle (VCL). Hepatic metabolism was analyzed using in vivo 13C/31P/1H and ex vivo 2H magnetic resonance spectroscopy before and during hyperinsulinemic-euglycemic clamps with isotope dilution. Mice underwent identical clamp procedures and hepatic transcriptome analyses. RESULTS: PO administration decreased whole-body, hepatic, and adipose tissue insulin sensitivity by 25%, 15%, and 34%, respectively. Hepatic triglyceride and ATP content rose by 35% and 16%, respectively. Hepatic gluconeogenesis increased by 70%, and net glycogenolysis declined by 20%. Mouse transcriptomics revealed that PO differentially regulates predicted upstream regulators and pathways, including LPS, members of the TLR and PPAR families, NF-κB, and TNF-related weak inducer of apoptosis (TWEAK). CONCLUSION: Saturated fat ingestion rapidly increases hepatic lipid storage, energy metabolism, and insulin resistance. This is accompanied by regulation of hepatic gene expression and signaling that may contribute to development of NAFLD.REGISTRATION. ClinicalTrials.gov NCT01736202. FUNDING: Germany: Ministry of Innovation, Science, and Research North Rhine-Westfalia, German Federal Ministry of Health, Federal Ministry of Education and Research, German Center for Diabetes Research, German Research Foundation, and German Diabetes Association. Portugal: Portuguese Foundation for Science and Technology, FEDER - European Regional Development Fund, Portuguese Foundation for Science and Technology, and Rede Nacional de Ressonância Magnética Nuclear.  
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
12.784
2.787
82
99
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Nf-kappa-b; Hepatic Glycogen-metabolism; Glucose-production; Acetaminophen Glucuronide; Inflammatory Response; Nondiabetic Humans; Diabetes-mellitus; Deuterated Water; Skeletal-muscle; Gene-expression
Language english
Publication Year 2017
HGF-reported in Year 2017
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Journal Journal of Clinical Investigation
Quellenangaben Volume: 127, Issue: 2, Pages: 695-708 Article Number: , Supplement: ,
Publisher American Society of Clinical Investigation
Publishing Place Ann Arbor
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes and Regeneration Research (IDR)
Institute of Experimental Genetics (IEG)
POF-Topic(s) 90000 - German Center for Diabetes Research
30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
Genetics and Epidemiology
PSP Element(s) G-501900-233
G-500600-004
G-500692-001
G-501900-062
G-500600-001
G-500600-006
G-501900-063
G-501900-025
DOI 10.1172/JCI89444
WOS ID WOS:000394164100029
Scopus ID 85014086154
PubMed ID 28112681
Erfassungsdatum 2017-03-01
[➜Report correction]